BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2019
View Archived Issues
A spoonful of sugar makes antigen work better
Read More
Coronavirus is PARP's side hustle
Read More
Mouse model devised for hypomyelination and atrophy of basal ganglia and cerebellum
Read More
Positive early results seen with E6/E7 RNA(LIP) cancer vaccine in first clinical study
Read More
New phase II trial studies HLX-10 for advanced MSI-H and dMMR solid tumors
Read More
First results from HD-CAR-1 trial on anti-CD19 CAR T cells for CD19+ lymphoid neoplasias
Read More
The Medicines Company reports long-term data on effects of inclisiran sodium on LDL-C
Read More
NX-13: a novel NLRX1-targeting immunometabolic therapeutic for UC
Read More
COX and LOX: For immune response, tolerance beats scorched-earth
Read More
First-in-human data with BIO89-100 support further development for NASH
Read More
SAkuraSky study shows satralizumab reduces relapse of neuromyelitis optica in AQP4-IgG+ patients
Read More
Kangpu initiates first-in-human study of KPG-818 for SLE
Read More
Bayer patents alpha2B-adrenoceptor antagonists
Read More
Heptares Therapeutics discloses new orexin OX1 receptor antagonists
Read More
GlaxoSmithKline presents new compounds for HIV infections
Read More
Novartis describes muscarinic M1-M5 receptor ligands
Read More
CC-220 generally well tolerated in pilot study in systemic lupus erythematosus
Read More
New compounds for obesity presented by Ube Industries
Read More
Entyvio approved in Japan for moderate to severely active Crohn's disease
Read More
DT-0111, a P2X2/3 receptor antagonist for COPD and chronic cough
Read More
Beta Bionics and Zealand initiate home-use trial of the iLet bionic pancreas with dasiglucagon
Read More
Autoantibodies against LL37 and ADAMTSL5 are elevated in psoriasis and psoriatic arthritis
Read More
Interim data from phase II study of Tavo with Keytruda in heavily pretreated metastatic TNBC
Read More
New dosage and administration of Genvoya approved in Japan for pediatric HIV-1 infection
Read More
Phase II study of mirikizumab in moderate to severely active Crohn's disease meets primary endpoint
Read More
Altasciences to guide development of RAP-103 peptide as chemical nerve agent therapeutic
Read More
Actemra approved in Japan for adult-onset Still's disease
Read More
Targovax reports 3-year survival data from phase I/II study of TG-101 in resected pancreatic cancer
Read More